Vascular wall maturation and prolonged angiogenic effect by endothelial-specific platelet-derived growth factor expression

Pathobiology

Volumn 73, Issue 3, 2006, Pages 149-158

  Levanon, Keren ^a,b,c   Varda Bloom, Nira ^a,b   Greenberger, Shoshana ^a,b,c   Barshack, Iris ^a,c   Goldberg, Iris ^a   Orenstein, Arie ^a   Breitbart, Eyal ^c   Shaish, Aviv ^a,c   Harats, Dror ^a,b,c  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c Vascular Biogenics Ltd   (Israel)

Author keywords

Adenovirus; Angiogenesis inducing agents; Endothelin 1; Endothelium, vascular; Gene therapy; Ischemia; Murine model; Platelet derived growth factor; Promoter regions; Vascular endothelial growth factor A

Indexed keywords

PLATELET DERIVED GROWTH FACTOR B; PREPROENDOTHELIN 1; VASCULOTROPIN;

ADENOVIRUS VECTOR; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PARAMETERS; BLOOD VESSEL WALL; CELL SPECIFICITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; DENSITY; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; GENE CONTROL; LIMB ISCHEMIA; MATURATION; MORPHOGENESIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERFUSION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY MECHANISM; SYSTEMIC THERAPY; THERAPY EFFECT; VASCULARIZATION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ADENOVIRIDAE; ANGIOGENESIS INDUCING AGENTS; ANIMALS; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; FEMALE; GENE THERAPY; GENETIC VECTORS; HINDLIMB; IMMUNOHISTOCHEMISTRY; ISCHEMIA; MICE; MICE, INBRED C57BL; MUSCLE, SMOOTH, VASCULAR; NEOVASCULARIZATION, PHYSIOLOGIC; PLATELET-DERIVED GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ADENOVIRIDAE; CYTOMEGALOVIRUS; MURINAE;

EID: 33750717545     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095561     Document Type: Article

References (42)

1. Henry TD, Annex BH, McKendall GR, Azrin MA, Lopez JJ, Giordano FJ, Shah PK, Willerson JT, Benza RL, Berman DS, Gibson CM, Bajamonde A, Rundle AC, Fine J, McCluskey ER: The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation 2003;107:1359-1365.
2. Hammond HK, McKirnan MD: Angiogenic gene therapy for heart disease: a review of animal studies and clinical trials. Cardiovasc Res 2001;49:561-567.
3. Rosengart TK, Lee LY, Patel SR, Kligfield PD, Okin PM, Hackett NR, Isom OW, Crystal RG: Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA. Ann Surg 1999;230:466-472.
4. Benjamin LE, Golijanin D, Itin A, Pode D, Keshet E: Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest 1999;103:159-165.
5. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E: Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1995;1:1024-1028.
6. Benjamin LE, Keshet E: Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci USA 1997;94:8761-8766.
7. Ware JA: Too many vessels? Not enough? The wrong kind? The VEGF debate continues. Nat Med 2001;7:403-404.
8. Betsholtz C, Karlsson L, Lindahl P: Developmental roles of platelet-derived growth factors. Bioessays 2001;23:494-507.
9. Hirschi KK, Rohovsky SA, Beck LH, Smith SR, D'Amore PA: Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact. Circ Res 1999;84:298-305.
10. Lee JA, Conejero JA, Mason JM, Parrett BM, Wear-Maggitti KD, Grant RT, Breitbart AS: Lentiviral transfection with the PDGF-B gene improves diabetic wound healing. Plast Reconstr Surg 2005;116:532-538.
11. Edelberg JM, Lee SH, Kaur M, Tang L, Feirt NM, McCabe S, Bramwell O, Wong SC, Hong MK: Platelet-derived growth factor-AB limits the extent of myocardial infarction in a rat model: feasibility of restoring impaired angiogenic capacity in the aging heart. Circulation 2002;105:608-613.
12. Hsu S, Huang F, Friedman E: Platelet-derived growth factor-B increases colon cancer cell growth in vivo by a paracrine effect. J Cell Physiol 1995;165:239-245.
13. Koyama N, Watanabe S, Tezuka M, Morisaki N, Saito Y, Yoshida S: Migratory and proliferative effect of platelet-derived growth factor in rabbit retinal endothelial cells: evidence of an autocrine pathway of platelet-derived growth factor. J Cell Physiol 1994;158:1-6.
14. Battegay EJ, Rupp J, Iruela-Arispe L, Sage EH, Pech M: PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors. J Cell Biol 1994;125:917-928.
15. Hao X, Mansson-Broberg A, Blomberg P, Dellgren G, Siddiqui AJ, Grinnemo KH, Wardell E, Sylven C: Angiogenic and cardiac functional effects of dual gene transfer of VEGF-A165 and PDGF-BB after myocardial infarction. Biochem Biophys Res Commun 2004;322:292-296.
16. Siddiqui AJ, Blomberg P, Wardell E, Hellgren I, Eskandarpour M, Islam KB, Sylven C: Combination of angiopoietin-1 and vascular endothelial growth factor gene therapy enhances arteriogenesis in the ischemic myocardium. Biochem Biophys Res Commun 2003;310:1002-1009.
17. Cao R, Brakenhielm E, Pawliuk R, Wariaro D, Post MJ, Wahlberg E, Leboulch P, Cao Y: Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 2003;9:604-613.
18. Breitbart AS, Grande DA, Laser J, Barcia M, Porti D, Malhotra S, Kogon A, Grant RT, Mason JM: Treatment of ischemic wounds using cultured dermal fibroblasts transduced retrovirally with PDGF-B and VEGF121 genes. Ann Plast Surg 2001;46:555-562.
19. Richardson TP, Peters MC, Ennett AB, Mooney DJ: Polymeric system for dual growth factor delivery. Nat Biotechnol 2001;19:1029-1034.
20. Harats D, Kurihara H, Belloni P, Oakley H, Ziober A, Ackley D, Cain G, Kurihara Y, Lawn R, Sigal E: Targeting gene expression to the vascular wall in transgenic mice using the murine preproendothelin-1 promoter. J Clin Invest 1995;95:1335-1344.
21. Varda-Bloom N, Shaish A, Gonen A, Levanon K, Greenbereger S, Ferber S, Levkovitz H, Castel D, Goldberg I, Afek A, Kopolovitc Y, Harats D: Tissue-specific gene therapy directed to tumor angiogenesis. Gene Ther 2001;8:819-827.
22. Bu X, Quertermous T: Identification of an endothelial cell-specific regulatory region in the murine endothelin-1 gene. J Biol Chem 1997;272:32613-32622.
23. Greenberger S, Shaish A, Varda-Bloom N, Levanon K, Breitbart E, Goldberg I, Barshack I, Hodish I, Yaacov N, Bangio L, Goncharov T, Wallach D, Harats D: Transcription-controlled gene therapy against tumor angiogenesis. J Clin Invest 2004;113:1017-1024.
24. Couffinhal T, Silver M, Zheng LP, Kearney M, Witzenbichler B, Isner JM: Mouse model of angiogenesis. Am J Pathol 1998;152:1667-1679.
25. Pajusola K, Kunnapuu J, Vuorikoski S, Soronen J, Andre H, Pereira T, Korpisalo P, Yla-Herttuala S, Poellinger L, Alitalo K: Stabilized HIF-1alpha is superior to VEGF for angiogenesis in skeletal muscle via adeno-associated virus gene transfer. FASEB J 2005;19:1365-1367.
26. Cosgrove D: Angiogenesis imaging - ultrasound. Br J Radiol 2003;76(spec No 1):S43-S49.
27. Jaggar RT, Chan HY, Harris AL, Bicknell R: Endothelial cell-specific expression of tumor necrosis factor-alpha from the KDR or E-selectin promoters following retroviral delivery. Hum Gene Ther 1997;8:2239-2247.
28. Ribault S, Neuville P, Mechine-Neuville A, Auge F, Parlakian A, Gabbiani G, Paulin D, Calenda V: Chimeric smooth muscle-specific enhancer/promoters: valuable tools for adenovirus-mediated cardiovascular gene therapy. Circ Res 2001;88:468-475.
29. Melo LG, Gnecchi M, Pachori AS, Kong D, Wang K, Liu X, Pratt RE, Dzau VJ: Endothelium-targeted gene and cell-based therapies for cardiovascular disease. Arterioscler Thromb Vasc Biol 2004;24:1761-1774.
30. Gill DR, Smyth SE, Goddard CA, Pringle IA, Higgins CF, Colledge WH, Hyde SC: Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter. Gene Ther 2001;8:1539-1546.
31. Qin L, Ding Y, Pahud DR, Chang E, Imperiale MJ, Bromberg JS: Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression. Hum Gene Ther 1997;8:2019-2029.
32. Gilead A, Neeman M: Dynamic remodeling of the vascular bed precedes tumor growth: MLS ovarian carcinoma spheroids implanted in nude mice. Neoplasia 1999;1:226-230.
33. Benjamin LE, Hemo I, Keshet E: A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 1998;125:1591-1598.
34. Barleon B, Siemeister G, Martiny-Baron G, Weindel K, Herzog C, Marme D: Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells. Cancer Res 1997;57:5421-5425.
35. Sjolund M, Rahm M, Claesson-Welsh L, Sejersen T, Heldin CH, Thyberg J: Expression of PDGF alpha- and beta-receptors in rat arterial smooth muscle cells is phenotype and growth state dependent. Growth Factors 1990;3:191-203.
36. Matsuura A, Yamochi W, Hirata K, Kawashima S, Yokoyama M: Stimulatory interaction between vascular endothelial growth factor and endothelin-1 on each gene expression. Hypertension 1998;32:89-95.
37. Margolis DJ, Cromblehome T, Herlyn M, Cross P, Weinberg L, Filip J, Propert K: Clinical protocol. Phase I trial to evaluate the safety of H5.020CMV.PDGF-b and limb compression bandage for the treatment of venous leg ulcer: trial A. Hum Gene Ther 2004;15:1003-1019.
38. Embil JM, Nagai MK: Becaplermin: recombinant platelet derived growth factor, a new treatment for healing diabetic foot ulcers. Expert Opin Biol Ther 2002;2:211-218.
39. Margolis DJ, Crombleholme T, Herlyn M: Clinical protocol: phase I trial to evaluate the safety of H5.020CMV.PDGF-B for the treatment of a diabetic insensate foot ulcer. Wound Repair Regen 2000;8:480-493.
40. Sano H, Sudo T, Yokode M, Murayama T, Kataoka H, Takakura N, Nishikawa S, Nishikawa SI, Kita T: Functional blockade of platelet-derived growth factor receptor-beta but not of receptor-alpha prevents vascular smooth muscle cell accumulation in fibrous cap lesions in apolipoprotein E-deficient mice. Circulation 2001;103:2955-2960.
41. Kaiser M, Weyand CM, Bjornsson J, Goronzy JJ: Platelet-derived growth factor, intimal hyperplasia, and ischemic complications in giant cell arteritis. Arthritis Rheum 1998;41:623-633.
42. Nesbit M, Schaider H, Berking C, Shih DT, Hsu MY, McBrian M, Crombleholme TM, Elenitsas R, Buck C, Herlyn M: Alpha5 and alpha2 integrin gene transfers mimic the PDGF-B-induced transformed phenotype of fibroblasts in human skin. Lab Invest 2001;81:1263-1274.